ADAM9 and thyroid gland carcinoma: However, RUNDC3A-AS1 has not been extensively studied, and it was currently discovered that RUNDC3A-AS1 regulated the malignant progression of thyroid cancer and can promote lung metastasis by targeting miR-182-5p/ADAM9 (38, 39).